Abstract:BACKGROUND: Sepsis is a condition of life-threatening organ dysfunction caused by a dysregulated host response to infection and carries a high risk of mortality. A rapidly growing number of “sepsis survivors” experience persistent and severe skeletal muscle weakness and atrophy (i.e., sepsis-induced myopathy). The myopathy is triggered by the interaction of circulating pathogens, inflammatory factors (e.g., cytokines and chemokines), and myofibers. Currently, there are no treatments for sepsis-induced myopathy partially due to a lack of therapeutic targets. Chemokines are peptides that possess chemo attractant properties and are released by immune cells during infection insult. Circulating levels of chemokines in septic patients are known to be high. However, the role these chemokines play in context of sepsis-induced myopathy is currently unknown. Our goal in this study was to identify the role of circulating chemokines on sepsis-induced myopathy. METHODS: We induced sepsis via cecal ligation and puncture (CLP) or sham control surgeries in a group of young adults (5 mo) male C57BL6 mice. Seven days after surgery, serum was collected from sham and CLP mice. The serum samples were pooled for cell culture experiments. In a subset of healthy mice, we isolated primary myoblasts. The myoblasts were co-cultured in conditioned media containing pooled serum samples collected from sham and CLP mice. We performed a multiplex assay to identify the levels of chemokines on the pooled serum samples. We measured myoblast proliferation, myotube area, and fusion index. In follow-up experiments, we exposed C2C12 myotubes to a selected group of chemokine peptides previously identified in serum samples. RESULTS: Exposure to septic serum attenuated the proliferative capacity of healthy myoblasts by 46% (p < 0.05). In addition, myoblasts exposed to septic serum did not differentiate into healthy myotubes. Multiplex analyses of pooled sham and septic serum revealed a marked elevation of the following chemokines: CXCL-1 (healthy = 173.4 ± 0.1, septic = 69,630 ± 13,732 pg/ml), CXCL-2 (healthy = 1,078 ± 0.1, septic = 3,907 ± 259 pg/ml), CXCL-10 (healthy = 366 ± 0.1, septic = 3,961 ± 293 pg/ml), CCL-2 (healthy = 276 ± 0.1, septic = 1672 ± 362 pg/ml). Exposure of mature C2C12 myotubes to the chemokine peptides for 24 h increased the mRNA expression of atrophy-related genes ( FOXO1, GABARAP, BNIP3, TRIM63, MAP11A3B, FOXO32, FOXO30). CONCLUSION: Circulating chemokines play a regulatory role in sepsis-induced myopathy via attenuation of the proliferative capacity of myoblasts and by altering myotube morphology and the expression of atrophy related genes. Chemokines are potential therapeutic targets to treat sepsis-induced myopathy. Funded by NIH R21AG072011-03 to OL This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

Sepsis-Induced Channelopathy in Skeletal Muscles is Associated with Expression of Non-Selective Channels

The role of circulatory chemokines in sepsis-induced myopathy in mice

Sepsis-induced myopathy.

Proteomic Profiling of Hindlimb Skeletal Muscle Disuse in a Murine Model of Sepsis

Impact of prolonged sepsis on neural and muscular components of muscle contractions in a mouse model

Sepsis-like Energy Deficit Is Not Sufficient to Induce Early Muscle Fiber Atrophy and Mitochondrial Dysfunction in a Murine Sepsis Model

Sepsis causes neutrophil infiltration in muscle leading to muscle atrophy and weakness in mice

SEPSIS LEADS TO IMPAIRED MITOCHONDRIAL CALCIUM UPTAKE AND SKELETAL MUSCLE WEAKNESS BY REDUCING THE MICU1:MCU PROTEIN RATIO

A Preclinical Model of Sepsis-Induced Myopathy with Disuse in Mice.

Chronic muscle weakness and mitochondrial dysfunction in the absence of sustained atrophy in a preclinical sepsis model

Skeletal Muscle and Lymphocyte Mitochondrial Dysfunctions in Septic Shock Trigger ICU-Acquired Weakness and Sepsis-Induced Immunoparalysis

Sepsis-Induced Myopathy and Gut Microbiome Dysbiosis: Mechanistic Links and Therapeutic Targets

Sepsis and the muscle tissue. A narrative review

Calpain activity and muscle wasting in sepsis

Skeletal Muscle Mitochondrial Dysfunction Mediated by Quorum Sensing Transcription Factor MvfR: Reversing Effects with Anti-MvfR and Mitochondrial-Targeted Compounds

Pathophysiological role of connexin and pannexin hemichannels in neuromuscular disorders

The impact of hindlimb disuse on sepsis‐induced myopathy in mice

Gut-muscle axis and sepsis-induced myopathy: The potential role of gut microbiota

Sciatic Denervation-Induced Skeletal Muscle Atrophy Is Associated With Persistent Inflammation And Increased Mortality During Sepsis

MECHANISMS OF CARDIAC DYSFUNCTION IN SEPSIS